Journey Medical Corp 8-K

What Happened

• Journey Medical Corporation (DERM) announced a corporate update and reported financial results for the three months ended March 31, 2026 via a press release dated May 13, 2026. The company furnished the press release as Exhibit 99.1 to its Form 8-K (Item 2.02), describing its quarterly results and corporate update. The filing states the information is being furnished (not “filed”) under the Exchange Act.

Key Details

• Filing: Form 8-K filed May 13, 2026, reporting results for the quarter ended March 31, 2026 (Item 2.02).
• Press release: Furnished as Exhibit 99.1 and dated May 13, 2026.
• Legal note: Information and Exhibit 99.1 are furnished and not subject to Section 18 liability and are not incorporated by reference into other filings unless explicitly stated.
• Technical exhibit: Inline XBRL cover page included as Exhibit 104.

Why It Matters

• This 8-K signals that Journey Medical has released its latest quarterly earnings and corporate update; investors should review the May 13 press release for revenue, earnings, cash position, and any operational or guidance details.
• Because the release is furnished (not filed), it carries more limited legal liability under the Exchange Act and is not automatically incorporated into future filings—so investors should rely on the actual press release and subsequent filings for definitive financial disclosure.